Welcome New Corporate Partners: LEO Pharma, Neurelis, UCSD Rady School of Management

Please join us in welcoming the following new corporate partners contributing their support to the HBA mission.


LEO Pharma
CEO: Christopher Posner, president & CEO, region U.S.
LEO Pharma helps people achieve healthy skin. The company is a leader in medical dermatology with a robust R&D pipeline, a wide range of therapies and a pioneering spirit. Founded in 1908, celebrating a decade in the U.S. and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions. LEO Pharma is headquartered in Denmark with a global team of 6,000 people, about 300 in the U.S., serving 76 million patients in 130 countries.


CEO : Craig Chambliss
Neurelis is a privately-held specialty pharmaceutical company based in San Diego.  The company was founded in 2007 to license, develop, and commercialize products for the central nervous system, including epilepsy and psychiatry.  The company’s lead product, ValtocoTM (diazepam nasal spray), is currently under review by the FDA.  

University of California San Diego, Rady School of Management
Dean: Lisa Ordóñez
The Rady School of Management at UC San Diego is a professional school within one of the top-ranked institutions in the U.S. for higher education and research. Established in 2003 and accredited by AACSB International (The Association to Advance Collegiate Schools of Business) in 2011, the Rady School is the only new business school created at a U.S. News & World Report top 10 ranked public research university during the past 30 years, and is one of the youngest in the nation ever to achieve AACSB recognition. In our 16 years, our students and alumni have developed over 182 companies to benefit others and impact the innovation economy in our region, state, country and the world. We will continue to recruit top faculty, attract leading student scholars, and create a climate for innovative business and research collaborations.